COVID-19 | The drug that reduces COVID mortality by 81%

COVID-19 | The drug that reduces COVID mortality by 81%
COVID-19 | The drug that reduces COVID mortality by 81%
In an information signed by Rafa Aranda, it is said that one of the drugs used since March at the beginning of the coronavirus pandemic in our country is cyclosporine, which was originally used to prevent rejection in organ donation operations. According to a first study carried out by researchers from the Quirónsalud Madrid University Hospital and the European University, it has been concluded that it has managed to reduce the mortality of the virus by 81%.
“We have discovered that the survival of patients who were treated with cyclosporine was higher compared to patients who were not treated with this treatment,” says the head of the Internal Medicine Service of the Quirónsalud Madrid University Hospital and professor at the European University, the Dr. Daniel Carnevali, in statements collected for 20 minutes. During the first months of the first wave of the coronavirus in Spain, many hospitals and health centers experimented with medicines and drugs that were used in other types of diseases with similar symptoms. “Hydroxychloroquine, antivirals like Lopinavir-ritonavir; antibiotics; corticosteroids and drugs that act in the inflammatory phase of the disease such as tozilizumab and cyclosporine, Carnevali cites.

How and when does cyclosporine work?

Cyclosporine is effective in the second phase of the disease, that is, with severe cases when pneumonia develops in the body and the patient is not able to respond adequately to the infection, leaving the lung quite weakened. As cyclosporine is effective in organ donation operations to contain the reaction of the immune system, it is also effective when it is the coronavirus that tries to act against the body.
More than 600 patients have received doses of this drug with positive results according to the study published in the scientific journal The Lancet, although Carnevali warns that it is retrospective: “It is not a randomized, double-blind study that compared drug to drug.” “Patients who have received cyclosporine are not essentially different from the rest,” he adds.

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!

These were the details of the news COVID-19 | The drug that reduces COVID mortality by 81% for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at en24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT The first comment from the Tunisian Renaissance Movement on the appointment...